Kraig Biocraft Laboratories Partners for Spider Silk Growth
ANN ARBOR, Mich. – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB), a pioneer in the development of spider silk technology, is announcing the near completion of a groundbreaking three-year collaboration with a prominent government agency in Southeast Asia. This strategic partnership aims to boost the scalability and security of its recombinant spider silk production capabilities.
Set to be officially signed soon, this important collaboration follows years of dedicated efforts to build relationships and demonstrate the effectiveness of Kraig Labs' innovative spider silk technologies. This agreement will open doors to advanced rearing facilities, essential infrastructure, and vital technical support previously unavailable to the company.
The collaboration will see Kraig Labs collaborating closely with government experts to refine and augment spider silk production processes. This partnership is expected to unveil substantial new production capacities, which will enable an expanded operation of hybridized silkworms.
Moreover, the partnership includes the establishment of parallel rearing operations, a critical factor in Kraig Labs’ long-term strategy to mitigate production risks and eliminate vulnerabilities within their supply chain. By spreading parent strain and egg production across multiple independent facilities, the company will enhance its throughput capacity and better position itself to meet increasing future demand.
Jon Rice, COO of Kraig Labs, expressed enthusiasm about the collaboration: "This is a transformative step forward in our goal to commercialize sustainable and cost-effective spider silk. The rare opportunity stems from our skilled team, our dedication to excellence, and significant progress in our field. This partnership equips us with strategic infrastructure and institutional backing to expand our production network while securing the reliability of our operations through distributed rearing and egg development systems."
Anticipated to commence operations in the near future, this collaboration will serve as a cornerstone in Kraig Labs' global strategy for spider silk manufacturing. It signifies growing confidence in the company's innovative biomaterials approach.
For continual updates on Kraig Labs and its advancements in spider silk technologies, visit www.kraiglabs.com.
About Kraig Biocraft Laboratories, Inc:
Kraig Biocraft Laboratories, Inc. (www.kraiglabs.com) stands at the forefront of genetically engineered spider silk-based fiber technology development. The company has reached several scientific milestones in spider silk technology, indicating significant implications for the global textile industry.
Frequently Asked Questions
What is the goal of the collaboration between Kraig Labs and the government agency?
The main goal is to expand the scale and security of spider silk production through improved rearing facilities and technical resources.
How will this partnership enhance Kraig Labs' production capabilities?
The partnership will allow for optimization of production processes and the scaling of hybridized silkworm operations, significantly boosting output.
What measures is Kraig Labs taking to mitigate production risks?
They are creating parallel rearing operations to distribute strain and egg production across multiple independent facilities, reducing vulnerabilities.
What are the potential benefits of spider silk technology?
Spider silk technology has the potential to revolutionize the textile industry by providing sustainable and cost-effective materials for various applications.
Who can I contact for more information about Kraig Labs?
You can reach out to Ben Hansel at Hansel Capital, Inc. at (720) 288-8495 or via email at ir@kraiglabs.com.
